SHELTON, CONNECTICUT / ACCESS Newswire / January 13, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a ...

Alfasigma S.p.A. (“Alfasigma”), a global pharmaceutical company, and Innovative Molecules GmbH (“Innovative Molecules”), a clinical-stage biotechnology company, today announced a strategic partnership ...

Members of a new class of antivirals are being tested in U.S. clinical trials, and one has gained approval in Japan, but how ...

New Study Shows SIK1 Strengthens Antiviral Immunity to Limit EV-D68–Induced Asthma Exacerbations Asthma is a chronic ...

MISSISSAUGA, ON / ACCESS Newswire / January 7, 2026 / Microbix Biosystems Inc. (Microbix®), a life sciences innovator, manufacturer, and exporter, announces the commercial usage of its first ...

Recent findings suggest that the Epstein-Barr virus (EBV) is involved in both causing multiple sclerosis (MS) and shaping its ...

Autoimmune diseases such as multiple sclerosis arise when the immune system turns against the body itself. Yet for most of ...

Human Immunodeficiency Virus (HIV) is a virus that attacks the body’s immune system, specifically the CD4 (T) cells, which ...

The 5,300-year-old Ötzi the Iceman mummy and a prehistoric man who lived in Siberia 45,000 years ago both carried a ...

The International Space Station (ISS) is a closed ecosystem, and the biology inside it — including its microbial residents — ...

Q: I heard about a Million Pound Challenge that was launched at the What’s Next Longevity Innovation Summit last December.

Which virus promises to be the worst in years this January? Why is this virus spreading fast, and what can we do to protect ...